Toronto - Delayed Quote CAD

Curaleaf Holdings, Inc. (CURA.TO)

1.1900
-0.0100
(-0.83%)
At close: May 23 at 4:00:00 PM EDT
Loading Chart for CURA.TO
  • Previous Close 1.2000
  • Open 1.1600
  • Bid 1.1800 x --
  • Ask 1.1900 x --
  • Day's Range 1.1600 - 1.2000
  • 52 Week Range 1.0050 - 6.6300
  • Volume 124,014
  • Avg. Volume 441,593
  • Market Cap (intraday) 901.293M
  • Beta (5Y Monthly) 1.14
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4600
  • Earnings Date Aug 5, 2025 - Aug 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.98

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of hemp-derived THC products through wholesale channels. The company is headquartered in Stamford, Connecticut.

www.curaleaf.com

5,519

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CURA.TO

View More

Performance Overview: CURA.TO

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CURA.TO
44.65%
S&P/TSX Composite index (^GSPTSE)
5.12%

1-Year Return

CURA.TO
81.58%
S&P/TSX Composite index (^GSPTSE)
16.57%

3-Year Return

CURA.TO
85.20%
S&P/TSX Composite index (^GSPTSE)
28.13%

5-Year Return

CURA.TO
93.70%
S&P/TSX Composite index (^GSPTSE)
73.53%

Compare To: CURA.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CURA.TO

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    901.29M

  • Enterprise Value

    1.91B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.48

  • Price/Book (mrq)

    0.80

  • Enterprise Value/Revenue

    1.05

  • Enterprise Value/EBITDA

    6.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -17.37%

  • Return on Assets (ttm)

    0.32%

  • Return on Equity (ttm)

    -20.92%

  • Revenue (ttm)

    1.31B

  • Net Income Avi to Common (ttm)

    -252.44M

  • Diluted EPS (ttm)

    -0.4600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    121.87M

  • Total Debt/Equity (mrq)

    110.19%

  • Levered Free Cash Flow (ttm)

    -105.46M

Research Analysis: CURA.TO

View More

Company Insights: CURA.TO

Research Reports: CURA.TO

View More

People Also Watch